Stocks
Biogen (BIIB) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 35.7% | 34.8% | 24.2% | 31.0% | 31.6% | 28.3% | ||
| Changes by years, y/y, % | -2pp | -1pp | -11pp | +7pp | +1pp | -3.6% | |||
Biogen. EBITDA margin, %
Biogen. EBITDA margin, changes, pp
Biogen (BIIB) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 42.0% | 33.7% | 9.31% | 22.3% | 2.86% | 28.3% | |
| Changes by years, y/y, % | +3pp | +5pp | -19pp | -13pp | -39pp | |||
| Changes by quarters, q/q, % | +6pp | -8pp | -24pp | +13pp | -19pp | |||
